Co-Diagnostics, Inc. — Director's Dealing 2022

Jun 7, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Co-Diagnostics, Inc. (CODX)
CIK: 0001692415
Period of Report: 2022-06-06

Reporting Person: Brown Brian Lee (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-06	Restricted Stock Units	$	A	225000.00	Acquired		Common Stock (225000.00)	Direct

Footnotes

F1: Granted pursuant to Issuer's 2015 Long Term Incentive Plan, as amended. Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's common stock.

F2: RSU vests in 6 installments commencing on 11/23/22 and continues every 6 months thereafter.